|
|
|
Corporate Overview
Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of cancer and inflammation-related diseases. Tragara launched operations in January 2007 and is focusing its development resources on two programs: (1) TP1001 for the treatment of inflammation related disorders and (2) TP2001 for the treatment of solid tumors.
Tragara is managed by a team of entrepreneurs with both Big Pharma and Biotech experience in the development and commercialization of oncology therapeutics. |
|
|
